| 2020-08 |
Radiation dose escalation can improve local disease control and survival among esophageal cancer patients with large primary tumor volume receiving definitive chemoradiotherapy |
PLoS ONE. 2020 Aug;15(8):Article number e0237114. |
 |
| 2020-05-26 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan |
Journal of Biomedical Science. 2020 May 26;27:Article number 69. |
|
| 2020-05-04 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort |
Scientific Reports. 2020 May 4;10:Article number 7420. |
|
| 2020-05 |
Impact of immune checkpoint inhibitors with or without a combination of tyrosine kinase inhibitors on organ-specific efficacy and macrovascular invasion in advanced hepatocellular carcinoma |
Oncology Research and Treatment. 2020 May;43(5):211-220. |
|
| 2020-05 |
Exploring Circulating Tumor Cells in cholangiocarcinoma using a novel glycosaminoglycan probe on a microfluidic platform |
Advanced Healthcare Materials. 2020 May;9(10):Article number 1901875. |
|
| 2020-02-27 |
Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer |
Radiation Oncology. 2020 Feb 27;15:Article number 48. |
|
| 2020-01 |
Review of preclinical and clinical studies of using cell-based therapy for secondary lymphedema |
Journal of Surgical Oncology. 2020 Jan;121(1):109-120. |
|
| 2020-01 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study |
European Journal of Cancer. 2020 Jan;124:123-130. |
|
| 2019-10-05 |
Percutaneous computed tomography-guided coaxial core biopsy for the diagnosis of pancreatic tumors |
Journal of Clinical Medicine. 2019 Oct 5;8(10):Article number 1633. |
|
| 2019-06-10 |
Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma |
BMC Cancer. 2019 Jun 10;19:Article number 560. |
|
| 2019-02 |
Mutational landscape by targeted next-generation sequencing in EBV-associated lymphoepithelioma-like cholangiocarcinoma |
Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number 269. |
|
| 2018-11 |
TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer |
Annals of Oncology. 2018 Nov;29(Suppl. 9):50. |
|
| 2018-10 |
Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study |
Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 736P. |
|
| 2018-05 |
A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers |
Journal of Clinical Oncology. 2018 May;36(15, Suppl. S):Meeting Abstract 2556. |
|
| 2017-09 |
Screening of peptide specific to cholangiocarcinoma cancer cells using an integrated microfluidic system and phage display technology |
Microfluidics and Nanofluidics. 2017 Sep;21(9):Article number 145. |
|
| 2017-07-01 |
Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform |
Biomicrofluidics. 2017 Jul 1;11(4):Article number 044101. |
|
| 2017-06-26 |
A microfluidic chip for detecting cholangiocarcinoma cells in human bile |
Scientific Reports. 2017 Jun 26;7:Article number 4248. |
|
| 2017-06 |
A new scoring system for primary central nervous system lymphoma - a retrospective multi-center analysis in Taiwan |
Haematologica. 2017 Jun;102(Suppl. 2):691-692. |
|
| 2017-05-04 |
Chemotherapy in the management of pancreatic cancer |
Pancreatic Cancer: With Special Focus on Topical Issues and Surgical Techniques. 2017 May 4:387-419. |
|
| 2017-05 |
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy |
Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531. |
|
| 2017-02 |
A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer |
Journal of Clinical Oncology. 2017 Feb;35(4, Suppl.):417. |
|
| 2016-11-21 |
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors |
BMC Cancer. 2016 Nov 21;16:Article number 907. |
|
| 2016-05-03 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer |
Scientific Reports. 2016 May 3;6:Article number 25369. |
|
| 2016-02 |
Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy |
Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 134. |
|
| 2016-02 |
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC) |
Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369. |
|
